We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
121 hedge funds and large institutions have $275M invested in ANI Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 35
37% more call options, than puts
Call options by funds: $6.29M | Put options by funds: $4.6M
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
2% less funds holding
Funds holding: 123 → 121 (-2)
32% less capital invested
Capital invested by funds: $402M → $275M (-$127M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
121
Holders Change
-2
Holders Change %
-1.63%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
21
Increased
48
Reduced
35
Closed
22
Calls
$6.29M
Puts
$4.6M
Net Calls
+$1.7M
Net Calls Change
-$9.61M
Top Buyers
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$17.5M |
| 2 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
-$5.13M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.18M |
| 4 |
TA
Teachers Advisors
New York
|
-$3.6M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$3.46M |
